Sensorion Full-Year 2021 Financial Results and Business Highlights - Press Release
Accelerating development of the OTOF-GT and GJB2-GT gene therapy programs in collaboration with Institut Pasteur Advancing SENS-401 joint clinical dev
Source: wiredprnews.com